BioCentury expands COVID-19 gateway to connect biotechs, researchers with COVID R&D consortium members

BioCentury has expanded the reach of its COVID-19 Resource Center to enable companies and researchers to submit details of investigational products directly to the pharma companies collaborating within the COVID R&D consortium.

The consortium, comprising more than a dozen top biopharma companies, is collaborating in a precompetitive forum to expedite the development of

Read the full 529 word article

How to gain access

Continue reading with a
two-week free trial.